HIMS
Get informed when a big investor buys or sells
+ FollowUndervalued by 221% based on the discounted cash flow analysis.
| Market cap | $6.90 Billion |
|---|---|
| Enterprise Value | $7.98 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.57 |
| Beta | 2.43 |
| Outstanding Shares | 231,746,126 |
| P/E Ratio | -50.69 |
|---|---|
| PEG | 16.73 |
| Price to Sales | 2.55 |
| Price to Book Ratio | 28.07 |
| Enterprise Value to Revenue | 3.09 |
| Enterprise Value to EBIT | -101.56 |
| Enterprise Value to Net Income | -57 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 5.21 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 74.82% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 69.33% |
|---|---|
| Total Invested | $774,541▼ 99.99% |
| Investors Holding | 9▼ 577.00% |
No data
Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermato...